INmune Bio Inc. (INMB) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Inmune Bio Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.973 Your program is about to begin. 00:00:07.317 -- 00:00:12.462 Greetings and welcome to the ImmuneBio third quarter 2025 earnings 00:00:12.462 -- 00:00:14.123 call. 00:00:14.123 -- 00:00:18.748 At this time, all participants are in a listen-only mode. 00:00:18.748 -- 00:00:23.011 Later, you will have the opportunity to ask questions during the question and answer 00:00:23.011 -- 00:00:24.653 session. 00:00:24.653 -- 00:00:30.473 You may register to ask questions by pressing the star and 1 on your telephone keypad. 00:00:30.473 -- 00:00:35.519 You may withdraw yourself from the queue by pressing star 2. 00:00:35.519 -- 00:00:39.444 As a reminder, this conference is being recorded. 00:00:39.444 -- 00:00:44.851 A transcript will follow within 24 hours of this conference call. 00:00:44.851 -- 00:00:48.415 At this time, it is my pleasure to introduce Mr. 00:00:48.415 -- 00:00:53.341 Daniel Carlson, Head of Investor Relations of Immune Bio. 00:00:53.341 -- 00:00:55.341 Daniel? 00:00:55.404 -- 00:00:58.165 Thank you, Operator, and good afternoon, everyone. 00:00:58.165 -- 00:01:02.990 We thank you for joining us for the call for ImmuneBio's third quarter 2025 financial 00:01:02.990 -- 00:01:07.995 results. Presenting on today's call are David Moss, CEO and co-founder of 00:01:07.995 -- 00:01:14.041 ImmuneBio, Dr. Mark Lodell, chief scientific officer and co-founder of ImmuneBio, 00:01:14.041 -- 00:01:19.907 Dr. CJ Barnum, head of neuroscience, and Corey Elsperman, ImmuneBio's CFO. 00:01:19.907 -- 00:01:24.491 Before we begin, I remind everyone that except for statements of historical fact, the 00:01:24.491 -- 00:01:29.159 statements made by management and responses to question on this conference call are forward-looking 00:01:29.159 -- 00:0...